Multidrug resistant Acinetobacter screen (multidrug resistant resistance)
Microbiology
Notes
- Multidrug resistant Acinetobacter species are defined as strains showing resistance to quinolones, cephalosporins, gentamicin, co-amoxiclav and piperacillin/tazobactam. They may also be resistant to carbapenems and colistin.
- Currently, screening for these organisms is only routinely done on the Intensive Care Units at both CGH and GRH sites when a patient is transferred from an ICU outside of the Trust.
- The following sites should be screened:
- Nose
- Throat
- Groin
- Urine (MSU or CSU)
- Sputum (if productive)
- Stool (or rectal swab)
- Wounds
- Screens should be performed on admission to the Critical Care Unit. Any positive results should be discussed with the ICT who will help direct any further testing.
- For further guidance and information please see Infection Control policy.
Sample requirements
Nose, thoat, groin, wound and rectal swabs
Standard charcoal transport swab
Place swab in transport medium
![Black top charcoal swab](https://www.gloshospitals.nhs.uk/media/images/Black_top_charcoal_swab.width-500.jpg)
Stool samples
![Stool container with spoon](https://www.gloshospitals.nhs.uk/media/images/Stool_container_with_spoon.width-500.jpg)
Sputum samples
![60ml wide-mouthed container](https://www.gloshospitals.nhs.uk/media/images/60-mL-pot.width-500.jpg)
Urine samples may be sent in either red or white capped 30 mL sterile universal containers.
Required information
- Reason for screening (e.g. transfer) and location of transferring hospital
- If testing is required for another healthcare provider
Storage/transport
Store and transport at room temperature
Turnaround time
Negative: 1-2 days
Positive: 2-3 days